1 / 8

3D Printed Drugs Market Are Expected To Provide Numerous Opportunities for the Market Growth

3D Printed Drugs Market is estimated to be $278 million in 2020, and would reach $522 million by 2030, growing at a CAGR of 6.5% from 2020 to 2030.

newmarketindustry
Download Presentation

3D Printed Drugs Market Are Expected To Provide Numerous Opportunities for the Market Growth

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Fraud Detection & Prevention Markt Skim Market Searket Market Met 3D Printed Drugs Market Global Opportunity Analysis & Industry Forecast, 2014-2022 Opportunity Analysis and Industry Forecast, 2014 - 2022 Global Opportunity Analysis and Industry Forecast, 2014-2022 Opportunity Analysis and Industry Forecast, 2014-2022 Global Opportunity Analysis and Industry Forecast 2030 Global Opportunity Analysis and Industry Forecast, 2014-2022 Global Opportunity Analysis and Industry Forecast, 2014 - 2022 Global Opportunity Analysis and Industry Forecast, 2017-2023 Global Opportunity Analysis and Industry Forecast 2030 Pages:125 Tables:24 Charts:56

  2. 3D Printed Drugs Market “Dysphagia is more prevalent in geriatric population and children, which results in difficulty while swallowing. 3D printed drugs are gaining popularity, as FDA has passed a priority review voucher system for it. In addition, increase in geriatric population and technological advancement in 3D pointing procedures are expected to contribute towards the growth of the market.” Pallavi Jaiswal Analyst, Healthcare Research at AMR

  3. 3D Printed Drugs Market Spritamis the only 3D printed drug available in the market since 2016 to treat epilepsy. The potential market for other 3D printed drugs (moderate growth scenario) is estimated to be $278 million in 2020, and would reach $522 million by 2030, growing at a CAGR of 6.5% from 2020 to 2030. U.S. market holds the highest market share in 2020. 3D printed drugs are medications created by 3D printing technology that are used to treat patients suffering from dysphagia. 3D printed drugs have porous structures that can disintegrate rapidly inside the mouth itself. Aprecia Pharmaceuticals Companys SPRITAM levetiracetam is the first 3D printed drug, which has been approved by the U.S. Food and Drug Administration (FDA) in August 2015.

  4. 3D Printed Drugs Market Constant technological developments in 3D printing technique, rise in incidence of epilepsy cases, and increase in awareness about the 3D printing technology in the developing countries drive the growth of the market. However, lack of government regulations related to these drugs and adverse effects of 3D printed drugs are expected to limit the market growth. The global 3D printed drugs market is analyzed based on forecast scenario such as low growth scenario, moderate growth scenario, and rapid growth scenario. Download Request Sample: https://www.alliedmarketresearch.com/request-sample/4508

  5. 3D Printed Drugs Market According to low growth scenario, the U.S. is anticipated to account for the highest market share in 2020, and rest of North America market is expected to grow at the highest rate, registering the CAGR of 5.1% by 2030. Europe is estimated to account for four-sevenths share in 2020, and is expected to dominate the market throughout the forecast period, due to presence of well-established healthcare systems and increase in prevalence of dysphagia. In addition, increase in adoption of 3D printed drugs is anticipated to provide new growth opportunities for the key players in the European market. Download Request Sample: https://www.alliedmarketresearch.com/request-sample/4508

  6. 3D Printed Drugs Market • Major Companies: • Aprecia Pharmaceuticals • GlaxoSmithKline Plc. • Hewlett Packard Caribe • BV LLC • 3D Printer Drug Machine • FabRxLtd.

  7. 3D Printed Drugs Market • Key Findings of 3D Printed Drugs Market: • In North America, the U.S. is anticipated to dominate the market in 2020, whereas rest of North America is projected to grow at the highest CAGR during the forecast period. • Germany was the major shareholder in the European 3D printed drugs market in 2016. • Asia-Pacific is expected to register the highest growth rate in future. • Australia is expected to grow at the highest CAGR in the Asia-Pacific 3D printed drugs market. • Send Enquiry on Report: https://www.alliedmarketresearch.com/purchase-enquiry/4508

  8. 3D Printed Drugs Market • Contact: • David Correa • 5933 NE Win Sivers Drive • #205, Portland, OR 97220 • United States • Toll Free (USA/Canada): • +1-800-792-5285, +1-503-894-6022, +1-503-446-1141 • UK: +44-845-528-1300 • Hong Kong: +852-301-84916 • India (Pune): +91-20-66346060 • Fax: +1⟨855⟩550-5975 • help@alliedmarketresearch.com • Web: https://www.alliedmarketresearch.com

More Related